Vitamin D Deficiency and Supplementation: US Prevalence and Guidance

Vitamin D deficiency is one of the most common and quietly consequential nutritional shortfalls in the United States, affecting bone density, immune function, and a growing list of health outcomes. This page covers how deficiency is defined and measured, the biological mechanisms behind vitamin D's role in the body, the populations most likely to fall short, and the practical thresholds that guide supplementation decisions. The evidence base draws primarily from the National Institutes of Health Office of Dietary Supplements and the Endocrine Society's clinical practice guidelines.

Definition and scope

The National Institutes of Health Office of Dietary Supplements defines vitamin D deficiency as a serum 25-hydroxyvitamin D [25(OH)D] level below 20 nanograms per milliliter (ng/mL), with insufficiency falling between 12 and 20 ng/mL (NIH ODS, Vitamin D Fact Sheet for Health Professionals). The Endocrine Society sets a slightly higher deficiency threshold — below 20 ng/mL — and considers levels below 30 ng/mL insufficient for optimal bone and muscle function (Endocrine Society Clinical Practice Guideline, 2011).

By NHANES (National Health and Nutrition Examination Survey) data, approximately 35 percent of U.S. adults have vitamin D insufficiency or deficiency, though rates vary significantly by race and ethnicity: roughly 17 percent of non-Hispanic white adults fall below 20 ng/mL, compared to approximately 82 percent of non-Hispanic Black adults (NHANES, cited by NIH ODS). That disparity is not random — it is driven by melanin's role in reducing cutaneous vitamin D synthesis, a biological fact with real clinical consequences that the nutrition field has been slow to address uniformly.

Vitamin D functions structurally as both a nutrient and a prohormone, which is part of what makes its deficiency so wide-reaching. It is covered in detail within the broader Micronutrients: Vitamins and Minerals reference, and its relationship to bone loss is explored in the Nutrition and Bone Health section.

How it works

Vitamin D enters the body through two primary routes: cutaneous synthesis triggered by UVB radiation (wavelengths 290–315 nm) and dietary intake from food or supplements. Neither route delivers the active hormone directly. The liver converts vitamin D2 or D3 into 25(OH)D — the storage and measurement form — and the kidneys then convert that into 1,25-dihydroxyvitamin D (calcitriol), the biologically active form.

Calcitriol binds to vitamin D receptors (VDRs) present in nearly every tissue type, including intestinal cells, osteoblasts, immune cells, and skeletal muscle. In the gut, it upregulates calcium absorption dramatically: adequate vitamin D enables absorption of approximately 30–40 percent of ingested calcium, while deficiency drops that figure to roughly 10–15 percent (NIH ODS). That single mechanism explains most of the vitamin's relationship to osteoporosis, rickets, and fracture risk.

The two supplemental forms — D2 (ergocalciferol) and D3 (cholecalciferol) — differ in potency and half-life. D3, derived from animal sources or lichen (for vegan formulations), raises serum 25(OH)D more effectively and sustains higher levels longer than an equivalent dose of D2 (Tripkovic et al., American Journal of Clinical Nutrition, 2012). For most supplementation protocols, D3 is the preferred form.

Common scenarios

Vitamin D deficiency does not look the same across all populations. The following groups face elevated risk through distinct mechanisms:

1. Older adults (65+): Cutaneous synthesis efficiency declines with age — skin produces roughly 75 percent less vitamin D per unit of UVB exposure in adults over 70 compared to young adults. Combined with reduced renal conversion capacity and lower dietary intake, this cohort is structurally vulnerable. See Nutrition for Older Adults for full context.

2. People with darker skin tones: Higher melanin concentrations act as a natural sunscreen, requiring 3 to 5 times longer UVB exposure to produce equivalent vitamin D levels compared to individuals with lighter skin (NIH ODS).

3. Pregnant and breastfeeding individuals: Breast milk is a poor source of vitamin D — it typically contains less than 25 IU per liter — making supplementation for breastfed infants a near-universal clinical recommendation. The prenatal dimension is detailed in Prenatal and Postpartum Nutrition.

4. People with obesity (BMI ≥ 30): Vitamin D is fat-soluble and sequesters in adipose tissue, reducing bioavailability. Clinical guidelines often recommend 2 to 3 times standard doses for this population to achieve target serum levels.

5. Individuals with malabsorptive conditions: Crohn's disease, celiac disease, and post-bariatric surgery states impair fat-soluble vitamin absorption, which includes all four fat-soluble vitamins (A, D, E, K).

Decision boundaries

The National Academy of Medicine (formerly the Institute of Medicine) sets the Recommended Dietary Allowance (RDA) for vitamin D at 600 IU/day for adults aged 19–70 and 800 IU/day for adults over 70 (NAM Dietary Reference Intakes, 2011). The Tolerable Upper Intake Level (UL) sits at 4,000 IU/day for adults — above which toxicity risk (hypercalcemia, soft-tissue calcification) becomes a clinical concern, though documented toxicity typically requires sustained doses above 10,000 IU/day.

The Endocrine Society's clinical guidelines, which target populations at high deficiency risk, suggest treatment doses of 1,500–2,000 IU/day for adults and up to 50,000 IU/week (as a short-term repletion protocol) for confirmed deficiency — a figure that sits well above the NAM's general public recommendation and reflects the gap between population-level guidance and clinical management.

The practical decision tree looks like this: serum 25(OH)D below 12 ng/mL warrants clinical treatment, not just supplementation; levels between 12 and 20 ng/mL typically call for supplementation in the 1,500–2,000 IU/day range; levels between 20 and 29 ng/mL are a judgment call based on individual risk factors; levels above 30 ng/mL generally require no intervention. Testing — via a simple serum 25(OH)D draw — is the only reliable way to make that determination, since sun exposure and diet history are poor proxies for actual status.

For those exploring the full landscape of micronutrient supplementation, the Dietary Supplements Overview section and the broader nutrition and diet reference at the site index provide structured entry points into adjacent topics including Omega-3 Fatty Acids and Fish Oil and Nutrition and Chronic Disease Prevention.